Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice

Journal of Neurochemistry

Volumn 95, Issue 4, 2005, Pages 1035-1046

  Nieto Cerón, Susana ^a   Del Campo, Luis F Sánchez ^a   Muñoz Delgado, Encarnación ^a   Vidal, Cecilio J ^a   Campoy, Francisco J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Acetylcholinesterase mRNAs; Glycosylphosphatidylinositol anchored proteins; Laminin; Peripheral blood lymphocytes

Indexed keywords

2 CYANO N (4 CYANOPHENYL) 3 CYCLOPROPYL 3 OXOPROPIONAMIDE; ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; AMPHOPHILE; ANTIBODY; CHOLINESTERASE; DIMER; GLYCOSYLPHOSPHATIDYLINOSITOL; LAMININ ALPHA2; LECTIN; MEROSIN; MONOMER; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE; HYDROPHILICITY; LAMA2DY GENE; LECTIN BINDING; MEROSIN DEFICIENCY; MOLECULAR SIZE; MOUSE; MOUSE STRAIN; MUSCULAR DYSTROPHY; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPINAL CORD; THYMUS; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ELECTROCHEMISTRY; IMMUNOPRECIPITATION; LAMININ; LECTINS; MICE; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMUS GLAND;

ANIMALIA;

EID: 28244492010     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03433.x     Document Type: Article

References (62)

1. Ando T., Fujii T. and Kawashima K. (1999) Expression of three acetylcholinesterase mRNAs in human lymphocytes. Jpn. J. Pharmacol. 79, 289P.
2. Bartha E., Rakonczay Z., Kasa P., Hollan S. and Gyevai A. (1987) Molecular forms of human lymphocyte membrane-bound acetylcholinesterase. Life Sci. 41, 1853-1860.
3. Botham C. A., Jones G. V. and Kendall M. D. (2001) Immuno- characterization of neuroendocrine cells in the rat thymus gland in vitro and vivo. Cell Tissue Res. 303, 381-389.
4. Bulloch K. and Bossone S. A. (1987) Nerve-related 3S acetylcholinesterase in murine thymus. Ann. N. Y. Acad. Sci. 496, 338-345.
5. Bulloch K. and Lucito R. (1988) The effects of cortisone on acetylcholinesterase (AChE) in the neonatal and aged thymus. Ann. N. Y. Acad. Sci. 521, 59-71.
6. Cabezas-Herrera J., Campoy F. J. and Vidal C. J. (1994a) Amphiphilic properties of molecular forms of acetylcholinesterase in normal and dystrophic muscle. J. Neurosci. Res. 38, 505-514.
7. 4 forms of acetylcholinesterase and butyrylcholinesterase in normal and dystrophic mouse muscle differ in their interaction with Ricinus communis agglutinin. Biochim. Biophys. Acta 1225, 283-288.
8. Cabezas-Herrera J., Moral-Naranjo M. T., Campoy F. J. and Vidal C. J. (1997) Glycosylation of acetylcholinesterase forms in microsomal membranes from normal and dystrophic Lama2dy mouse muscle. J. Neurochem. 69, 1964-1974.
9. Cavallotti D., Artico M., Cavallotti C., Iannetti G. and Frati A. (2000a) Acetylcholinesterase activity in rat thymus after immunostimulation with interleukin β. Ann. Anat. 182, 243-248.
10. Cavallotti D., Artico M., Iannetti G. and Cavallotti C. (2000b) Quantification of acetylcholinesterase-positive structures in human thymus during development and aging. Neurochem. Int. 36, 75-82.
11. Darreh-Shori T., Hellström-Lindahl E., Flores-Flores C., Guan Z. Z., Soreq H. and Nordberg A. (2004) Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J. Neurochem. 88, 1102-1113.
12. Feltri M. L., Porta D. G., Previtali S. C. et al. (2002) Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 156, 199-209.
13. Feng G., Krejci E., Molgo J., Cunningham A., Massoulié J. and Sanes J. R. (1999) Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J. Cell Biol. 144, 1349-1360.
14. Flores-Flores C., Martínez-Martínez A., Muñoz-Delgado E. and Vidal C. J. (1996) Conversion of acetylcholinesterase hydrophilic tetramers into amphiphilic dimers and monomers. Biochem. Biophys. Res. Commun. 219, 53-58.
15. Gómez J. L., García-Ayllón M. S., Campoy F. J. and Vidal C. J. (2000) Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2dy mice. J. Neurosci. Res. 62, 134-145.
16. Gómez J. L., Nieto-Cerón S., Campoy F. J., Muñoz-Delgado E. and Vidal C. J. (2003) Purification and properties of hydrophilic dimers of acetylcholinesterase from mouse erythrocytes. Int. J. Biochem. Cell Biol 35, 1109-1118.
17. Grisaru D., Sternfeld M., Eldor A., Glick D. and Soreq H. (1999) Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264, 672-686.
18. Hooper N. M. (2001) Determination of glycosyl-phosphatidylinositol membrane protein anchorage. Proteomics 1, 748-755.
19. Iwao M., Fukada S., Harada T., Tsujikawa K., Yagita H., Hiramine C., Miyagoe Y., Takeda S. and Yamamoto H. (2000) Interaction of merosin (laminin-2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes. Immunology 99, 481-488.
20. Kawashima K. and Fujii T. (2000) Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther. 86, 29-48.
21. Layer P. G. and Willbold E. (1995) Novel functions of cholinesterases in development, physiology and disease. Prog. Histochem. Cytochem. 29, 1-94.
22. Lev-Lehman E., Ginzberg D., Hornreich G., Ehrlich G., Meshorer A., Eckstein F., Soreq H. and Zakut H. (1994) Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo. Gene Ther. 2, 1-9.
23. Li B., Stribley J. A., Ticu A., Xie W., Schopfer L. M., Hammond P., Brimijoin S., Hinrichs S. H. and Lockridge O. (2000) Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75, 1320-1331.
24. Li Y., Camp S., Rachinsky T. L., German D. and Taylor P. (1991) Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression. J. Biol. Chem. 266, 23083-23090.
25. Magner W. J., Chang A. C., Owens J., Hong M. J., Books A. and Coligan J. E. (2000) Aberrant development of thymocytes in mice lacking laminin-2. Dev. Immunol. 1, 179-193.
26. Maslinski W., Grabczewska E., Laskowska-Bozek H. and Ryzewski J. (1987) Expression of muscarinic cholinergic receptors during T cell maturation in the thymus. Eur. J. Immunol. 17, 1059-1063.
27. Massoulié J., Anselmet A., Bon S., Krejci E., Legay C., Morel N. and Simon S. (1999) The polymorphism of acetylcholinesterase: posttranslational processing, quaternary associations and localization. Chem. Biol Interact. 119-120, 29-42.
28. Micic M., Leposavic G. and Ugresic N. (1994) Relationships between monoaminergic and cholinergic innervation of the rat thymus during aging. J. Neuroimmunol. 49, 205-212.
29. Mihovilovic M. and Butterworth-Robinette J. (2001) Thymic epithelial cell line expresses transcripts encoding α-3, β-5 and β-4 subunits of acetylcholine receptors, -responds to cholinergic agents and expresses choline acetyl transferase. An in vitro system to investigate thymic cholinergic mechanisms. J. Neuroimmunol. 17, 58-67.
30. Miyagoe-Suzuki Y., Nakagawa M. and Takeda S. (2000) Merosin and congenital muscular dystrophy. Microsc. Res. Tech. 48, 181-191.
31. Moral-Naranjo M. T., Cabezas-Herrera J. and Vidal C. J. (1996) Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43, 224-234.
32. Moral-Naranjo M. T., Cabezas-Herrera J., Campoy F. J. and Vidal C. J. (1997) Differential glycosylation of asymmetric acetylcholinesterase forms in external and internal muscle membranes. Biochem. Soc. Trans. 25, 441S.
33. Moral-Naranjo M. T., Campoy F. J., Cabezas-Herrera J. and Vidal C. J. (1999) Increased butyrylcholinesterase levels in microsomal membranes of dystrophic Lama2dy mouse muscle. J. Neurochem. 73, 1138-1144.
34. Moral-Naranjo M. T., Cabezas-Herrera J., Vidal C. J. and Campoy F. J. (2002) Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice. Neurosci. Lett. 331, 155-158.
35. Nieto-Cerón S., Moral-Naranjo M. T., Muñoz-Delgado E., Vidal C. J. and Campoy F. J. (2004) Molecular properties of acetylcholinesterase in mouse spleen. Neurochem. Int. 45, 129-139.
36. Patinkin D., Seidman S., Eckstein F., Benseler F., Zakut H. and Soreq H. (1990) Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro. Mol. Cell. Biol. 10, 6046-6050.
37. Pear W. S., Tu L. and Stein P. L. (2004) Lineage choices in the developing thymus: choosing the T and NKT pathways. Curr. Opin. Immunol 16, 167-173.
38. Ferner A. L., Massoulié J. and Krejci E. (2002) PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33, 275-285.
39. Perry C., Sklan E. H., Birikh K., Shapira M., Trejo L., Eldor A. and Soreq H. (2002) Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21, 8428-8441.
40. Qiu Y., Peng Y. and Wang J. (1996) Immunoregulatory role of neurotransmiters. Adv. Neuroimmunol. 6, 223-231.
41. Rachinsky T. L., Camp S., Li Y., Ekström T. J., Newton M. and Taylor P. (1990) Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species. Neuron 5, 317-327.
42. Randall W. R. (1994) Cellular expression of a cloned, hydrophilic, murine acetylcholinesterase. Evidence of palmitoylated membrane-bound forms. J. Biol. Chem. 269, 12 367-12 374.
43. Rinner I., Kukulanski T., Felsner P., Skreiner E., Globerson A., Kasai M., Hirokawa K., Korsatko W. and Schauenstein K. (1994) Cholinergic stimulation modulates apoptosis and differentiation of murine thymocytes via a nicotinic effect on thymic epithelium. Biochem. Biophys. Res. Commun. 203, 1057-1062.
44. Rinner I., Felsner P., Liebmann P. M., Hofer D., Wölfler A., Globerson A. and Schauenstein K. (1998) Adrenergic/cholinergic immunomodulation in the rat model: in vivo veritas? Dev. Immunol. 6, 245-252.
45. Rinner I., Globerson A., Kawashima K., Korsatko W. and Schauenstein K. (1999) A possible role for acetylcholine in the dialogue between thymocytes and thymic stroma. Neuroimmunomodulation 6, 51-55.
46. Rodgers K. E. and Ellefson D. D. (1990) Modulation of respiratory burst activity and mitogenic response of human peripheral blood mononuclear cells and murine splenocytes and peritoneal cells by malathion. Fundam. Appl. Toxicol. 14, 309-317.
47. Rossi A., Tria M. A., Baschieri S., Doria G. and Frasca D. (1989) Cholinergic agonists selectively induce proliferative responses in the mature subpopulation of murine thymocytes. J. Neurosci. Res. 24, 369-373.
48. Rossi A., Vicini E., Scarsella G. and Biagioni S. (1991) Acetylcholinesterase distribution in subpopulations of murine thymocyte. J. Neurosci. Res. 29, 201-206.
49. Ruiz-Espejo F., Cabezas-Herrera J., Illana J., Campoy F. J., Muñoz-Delgado E. and Vidal C. J. (2003) Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes. Breast Cancer Res. Treat. 80, 105-114.
50. Sasaki T., Giltay R., Talts U., Timpl R. and Talts J. F. (2002) Expression and distribution of laminin alpha 1 and alpha 2 chains in embryonic and adult tissues: an immunochemical approach. Exp. Cell Res. 275, 185-199.
51. Spencer M. J. and Tidball J. G. (2001) Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromusc. Disord. 11, 556-564.
52. Taylor P. and Radic Z. (1994) The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281-320.
53. Tomé F. M. S. (1999) The saga of congenital muscular dystrophy. Neuropediatrics 30, 55-65.
54. Topilko A. and Kaillou B. (1985) Acetylcholinesterase in human thymus cells. Blood 66, 891-895.
55. Toutant J. P., Richards M. K., Krall J. A. and Rosenberry T. L. (1990) Molecular forms of acetylcholinesterase in two sublines of human erythroleukemia K562 cells. Sensitivity or resistance to phosphatidylinositol specific phospholipase C and biosynthesis. Eur. J. Biochem. 187, 31-38.
56. Uccelletti D., De Jaco A., Farina A., Mancini P., Augusti-Tocco G., Biagioni S. and Palleschi C. (2002) Cell surface expression of a GPI-anchored form of mouse acetylcholinesterase in KlpmrIΔ cells of Kluyveromyces lactis. Biochem. Biophys. Res. Commun. 298, 559-565.
57. Vachon P. H., Xu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J. C., Wewer U. M. and Engvall E. (1997) Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100, 1870-1881.
58. Wakkach A., Guyon T., Bruand C., Tzartos S., Cohen-Kaminsky S. and Berrih-Aknin S. (1996) Expression of acetylcholine receptor genes in human thymic epithelial cells. J. Immunol. 157, 3752-3760.
59. Webb C. P., Nedergaard S., Giles K. and Greenfield S. A. (1996) Involvement of the NMDA receptor in a non-cholinergic action of acetylcholinesterase in guinea-pig substantia nigra pars compacta neurons. Eur. J. Neurosci. 8, 837-841.
60. Wessler I., Kilbinger H., Bittinger F., Unger R. and Kirkpatrick C. J. (2003) The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 72, 2055-2061.
61. Xu H., Wu X.-R., Wewer U. M. and Engvall E. (1994) Murine muscular dystrophy caused by a mutation in the laminin alfa2 (Lama2) gene. Nat. Genet. 8, 297-302.
62. Zhang X. J., Yang L., Zhao Q., Caen J. P., He H. Y., Jin Q. H., Guo L. H., Alemany M., Zhang L. Y. and Shi Y. F. (2002) Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ. 9, 790-800.